Allergic Rhinitis Clinical Trial
Official title:
Home Usability of a Nasal Lavage System in Children
This study evaluates labeling comprehension, ease of use and effectiveness of a new device for nasal and sinus irrigation and/or aspiration. The device is currently cleared for professional use and home use with a prescription. This is a usability study to demonstrate that this device is appropriate for home use.
Nasal congestion is an important complication of viral upper respiratory infections in young
children. It can lead to poor eating, sleeping and breathing. Recently, the FDA recommended
against using over-the-counter cold remedies in young children because of inefficacy and
occasional dangerous side effects. A commonly recommended non-drug solution for nasal
congestion is nasal suctioning. This can be effective but currently available methods have
been found to be awkward, uncomfortable and ineffective.
The studied device has potential for making nasal suctioning easy to perform in the home
setting, especially in young children. It is already FDA cleared for professional use and
this study was developed to demonstrate that it is appropriate for the home as well. This
would be significant as it would allow parents a strategy of clearing their child's nose
without drugs.
The device is automatic and handheld that can irrigate and/or aspirate the nasal cavity with
hospital-grade suction. The handle houses a pump that can achieve air flows known to be
effective for infant nasal suctioning in the hospital. A disposable wash-head is placed on
top. It has an irrigation chamber with 0.9% saline and another chamber for collecting the
aspirated nasal contents. The unit operates from a single bi-functional button.
Several key safety features have been built in such as: a tip that is shaped to maximize the
seal but prevent intrusion into the nose; an irrigation function that delivers an optimal
volume but prevents flooding the nasal cavity; and a pump that can deliver suction known to
be effective in the hospital but whose safety valve does not allow it to rise above
dangerous levels.
Participants were parents of children who have nasal congestion for whom nasal suctioning is
traditionally recommended. They were asked to review the instruction manual of the device,
and then use it on their children.
The primary outcome was proper use of device that was precisely defined. Additionally,
subjective efficacy of mucus removal, evidence of adverse events and understanding of the
device's user manual were also measured.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05080322 -
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
|
Phase 4 | |
Recruiting |
NCT06028490 -
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
|
Phase 2 | |
Completed |
NCT04388358 -
Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation
|
N/A | |
Recruiting |
NCT04202263 -
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
|
Phase 2 | |
Completed |
NCT04078009 -
Standardising Nasal Allergen Challenge in Adult With Hay Fever
|
N/A | |
Completed |
NCT03644680 -
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
|
N/A | |
Completed |
NCT04541004 -
Adolescent Mite Allergy Safety Evaluation
|
Phase 3 | |
Recruiting |
NCT05378594 -
HDM and Silver Birch NAC Standardisation
|
N/A | |
Not yet recruiting |
NCT05684380 -
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
|
Phase 3 | |
Not yet recruiting |
NCT01014325 -
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
|
Phase 3 | |
Completed |
NCT02910401 -
Clinical Response to Rhinovirus Challenge
|
Phase 2 | |
Completed |
NCT02943720 -
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
|
Phase 2 | |
Completed |
NCT02556801 -
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
|
Phase 2 | |
Not yet recruiting |
NCT02233426 -
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
|
N/A | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01918956 -
PURETHAL Birch RUSH Study
|
Phase 4 | |
Completed |
NCT01946035 -
Alpha-Blockers in Allergic Rhinitis (MAN 01)
|
Phase 4 | |
Completed |
NCT01682070 -
SUBLIVAC FIX Phleum Pratense DT/DRF
|
Phase 2 | |
Recruiting |
NCT01454492 -
The Relationship Between Allergic Rhinitis and Geographic Tongue
|
N/A | |
Completed |
NCT01438463 -
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis
|
Phase 2 |